Gan & Lee Pharmaceuticals Presented Multiple Results in Novel Diabetes Therapies at the American Diabetes Association's 85th Scientific Sessions ...Middle East

In a Phase 2a clinical trial, the GLP-1 RA bofanglutide injection demonstrated a favorable safety and tolerability profile after 23 weeks of once weekly treatment in patients with type 2 diabetes mellitus (T2DM), with significant HbA1c reductions alongside comprehensive benefits for body...

Read More Details
Finally We wish PressBee provided you with enough information of ( Gan & Lee Pharmaceuticals Presented Multiple Results in Novel Diabetes Therapies at the American Diabetes Association's 85th Scientific Sessions )

Also on site :

• Planting the seeds for remembering
• Prabowo hails BRICS entry, reaffirms Indonesia’s non-aligned stance
• Legendary ’70s Actor Seen in Rare Outing With Much Younger Girlfriend